Moderna Inc. stock - "The end of a pandemic Stock"
Moderna, a drugmaker with just a single product to its name
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
, has become perhaps the best-known biotech in the world over the past four months, with nearly 100 million doses of its Covid-19 vaccine administered in the U.S. alone.
Shares of Moderna Inc. MRNA, +5.56% slid 9.72% to $111.40 Monday, on what proved to be an all-around favourable
trading session for the stock market, with the NASDAQ Composite Index
#moderna #mrna #Mrna
면책사항
이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.